Posted by Michael Wonder on 30 Jun 2020
EMA and Korean Ministry of Food and Drug Safety to share confidential COVID-19 information
30 June 2020 - EMA and the Ministry of Food and Drug Safety of the Republic of Korea have signed an agreement that allows them to share confidential information on medicines intended for the treatment, diagnosis, or prevention of COVID-19.
COVID-19 is a global public health emergency. EMA is committed to working with international regulators to help streamline the regulatory requirements for the generation of evidence for COVID-19 therapeutics and medicines to help speed up their development in the interest of patients worldwide.
